1. Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line
   Jeyan Jayarajan et al, 2020, Molecular Biology Reports CrossRef
2. Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
   Sepideh Mirzaei et al, 2021, Antioxidants CrossRef
3. Improvements in Drug-Delivery Properties by Co-Encapsulating Curcumin in SN-38-Loaded Anticancer Polymeric Nanoparticles
   Lisa Silverman et al, 2022, Molecular Pharmaceutics CrossRef
4. Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
   Milad Ashrafizadeh et al, 2020, Pharmaceutics CrossRef
5. S100A8 inhibition in leukemic lymphoblasts induces sensitivity to chemotherapy and inhibition of disease relapse
   Mohamad Javad Hejazi et al, 2022, Medical Oncology CrossRef
6. Advances in the pharmaceutical research of curcumin for oral administration
   Cheng Li et al, 2023, Open Chemistry CrossRef
7. Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
   Julie Mondet et al, 2021, Molecules CrossRef
8. Targeting Drug Chemo-Resistance in Cancer Using Natural Products
   Wamidh H. Talib et al, 2021, Biomedicines CrossRef
9. S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma
   Qi Lin et al, 2024, Frontiers in Oncology CrossRef
10. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
    Tracey Immanuel et al, 2022, Frontiers in Oncology CrossRef